Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansPerlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesispH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and releaseThe anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent mannerEndorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonismEndorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cellsBiosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and propertiesCell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells.NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrinInfluence of charge state and sodium cationization on the electron detachment dissociation and infrared multiphoton dissociation of glycosaminoglycan oligosaccharidesA central function for perlecan in skeletal muscle and cardiovascular developmentPerlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissuesHallmarks of glycosylation in cancerThe role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagyRole of heparan sulfate in sexually transmitted infectionsExtracellular Matrix, a Hard Player in AngiogenesisEssential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesisNewly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinasesSpacrcan binding to hyaluronan and other glycosaminoglycans. Molecular and biochemical studiesHeparan sulfate signaling in cancerSynthesis of Anticoagulantly Active Heparan Sulfate Proteoglycans by Glomerular Epithelial Cells Involves Multiple 3-O-Sulfotransferase Isoforms and a Limiting Precursor PoolMechanisms of heparanase inhibitors in cancer therapy.A current view of perlecan in physiology and pathology: A mosaic of functions.Smooth muscle specific deletion of Ndst1 leads to decreased vessel luminal area and no change in blood pressure in conscious miceGlycomics approaches for the bioassay and structural analysis of heparin/heparan sulphatesHeparan sulfate: lessons from knockout miceA novel interaction between perlecan protein core and progranulin: potential effects on tumor growth.The Drosophila Perlecan gene trol regulates multiple signaling pathways in different developmental contexts.The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma.Quantitative evaluation of experimental choroidal neovascularization by confocal scanning laser ophthalmoscopy: fluorescein angiogram parallels heparan sulfate proteoglycan expression.Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.Endorepellin evokes autophagy in endothelial cellsGlycosaminoglycans detection methods: Applications of mass spectrometry.Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasisAngiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycansMicroarray method for the rapid detection of glycosaminoglycan-protein interactionsTumorigenic and adhesive properties of heparanase.WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling
P2860
Q21710680-E0EA7649-10B3-4538-8DE4-2010A92478EDQ24295251-AD896B68-366D-4AD6-A06B-79B7A4744282Q24298247-94498A4F-B6A0-4997-B361-B6DD1454204FQ24302060-0B85ADD3-CF9F-44D5-87F4-B27ED9FE6F5FQ24303934-20B2680C-42E1-4C9A-AA05-E93C47739515Q24312922-89ADF6EA-CB7C-44F3-9C90-7B02D9C0FC2EQ24535653-09A76472-706F-485B-9D42-F0BB7EA907F9Q24538924-A073F6EE-DACF-44B9-8145-2E48F534EAC2Q24561606-2BEB4B9C-D319-4D4E-A02E-F26B11B92416Q24641851-1499BBEF-E490-448A-8ED6-D52BF69EC27FQ24648227-05EBB9F2-380B-4FFA-AFAD-DB3AF65F9BACQ24653433-59464DE8-010C-41F8-B8C2-8A7E3071AEC7Q24681471-7612582F-727E-4A00-8745-9DBFC81732B1Q26752363-5AB7314C-70E7-4020-9FA6-B2CD229522EDQ26800258-1648F521-DFC4-427B-9E86-C0FE6D7C39AFQ27023959-977C28D2-AEC6-4FA4-98EF-4F22F9899EC1Q28072886-2EC48835-F5E0-45A0-BB79-F02B09C34E2AQ28294512-5B51DD78-E8CE-4E97-A293-5DF893C7D543Q28475274-A39C92D5-E8CE-479B-88CC-52DEAF2B89CEQ28505697-93408984-832F-4B8B-A49A-CC28A184AED2Q28657828-D70D880B-3118-437D-9819-AA54E6735660Q29041276-5828196B-F227-47BA-AD06-34A665CCCA06Q30244089-2F7E27F2-889D-450C-89EE-0FA3525B1438Q30392738-CE178B81-8D5A-4DB4-810D-F1CF4A919E52Q30419052-E315801D-83A3-4521-9A9D-216589C7FF3CQ30437948-79C15195-92A5-4E24-ADD1-AF990D7A5B23Q30689506-790B68D3-0B98-4CAA-A437-D3F15B212350Q33292070-B15B5C0D-60D5-4FA8-A45F-3ABBDB627D86Q33304884-2819F81A-7880-4B90-9406-B49735ED0A9EQ33361929-8F177F74-8EA0-44BD-825D-389892AA03FFQ33520086-E4DA5D5F-586C-4822-A9C0-B4788111E51FQ33577041-65FA852A-A0FE-45E7-9012-CECEBC564194Q33665623-F16D6DB0-74A0-44E0-BBE0-038A2CCD3871Q33718473-9772690F-6E33-4448-B70B-ADBCDC626E05Q33816146-0AC6E876-B5EF-4C31-97B7-E7D95F5AB527Q33894102-23543790-E51F-41D5-B86F-6BFD39AA8CF0Q33914700-63035CDB-2526-4606-895B-25D8D205162CQ34065019-CF805072-44E1-4617-AED8-A7B5A60819E3Q34137792-B0F86420-9BB4-48AD-9535-2A8C86208C05Q34186700-E651444C-93D9-48BF-8EA4-59593ABE2899
P2860
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@ast
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@en
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@nl
type
label
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@ast
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@en
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@nl
prefLabel
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@ast
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@en
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@nl
P2860
P356
P1476
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
@en
P2093
J D San Antonio
P2860
P304
P356
10.1172/JCI200113738
P407
P577
2001-08-01T00:00:00Z